Cargando…
Rapid Protocol Development, Study Startup and Enrolment of a Prospective Study of COVID-19 Vaccination for Patients with Cancer: A Collaborative Approach
Background: COVID-19 is an unprecedented global health emergency. It has been highly disruptive for patients with cancer, both due to an increased burden of severe illness and due to pressure on healthcare systems. COVID-19 vaccination has been an important public health measure for this patient gro...
Autores principales: | Body, Amy, Milch, Vivienne, McSorley, Lynda, Lal, Luxi, Ahern, Elizabeth, Ryan, Regina, Jones, Gayle, Keefe, Dorothy, Segelov, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785949/ https://www.ncbi.nlm.nih.gov/pubmed/36560412 http://dx.doi.org/10.3390/vaccines10122003 |
Ejemplares similares
-
286P Breakthrough COVID-19 infections in patients with cancer from a prospective study of COVID-19 vaccine response
por: Body, A., et al.
Publicado: (2022) -
COVID-19 recovery: implications for cancer care clinicians
por: Delany, Clare, et al.
Publicado: (2021) -
Protocol for SARS-CoV-2 post-vaccine surveillance study in Australian adults and children with cancer: an observational study of safety and serological and immunological response to SARS-CoV-2 vaccination (SerOzNET)
por: Body, Amy, et al.
Publicado: (2022) -
1611P Clinical determinants of SARS-CoV-2 vaccine response in adults with cancer
por: Segelov, E., et al.
Publicado: (2022) -
Survey of startup
Publicado: (1981)